GKIM
RDY icon

GW&K Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

GW&K Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,075
Closed -$15K – 955
2023
Q4 		$15K Hold
1,075
– – ﹤0.01% 577
2023
Q3 		$14K Hold
1,075
– – ﹤0.01% 546
2023
Q2 		$14K Hold
1,075
– – ﹤0.01% 532
2023
Q1 		$12K Buy
1,075
+50
+5% +$540 ﹤0.01% 391
2022
Q4 		$11K Hold
1,025
– – ﹤0.01% 366
2022
Q3 		$11K Hold
1,025
– – ﹤0.01% 354
2022
Q2 		$11K Hold
1,025
– – ﹤0.01% 466
2022
Q1 		$11K Sell
1,025
-5,110
-83% -$57.9K ﹤0.01% 433
2021
Q4 		$80K Sell
6,135
-555
-8% -$7K ﹤0.01% 352
2021
Q3 		$87K Sell
6,690
-285
-4% -$3.8K ﹤0.01% 348
2021
Q2 		$103K Hold
6,975
– – ﹤0.01% 342
2021
Q1 		$86K Buy
6,975
+10
+0.1% +$128 ﹤0.01% 349
2020
Q4 		$99K Buy
6,965
+440
+7% +$5.92K ﹤0.01% 338
2020
Q3 		$91K Buy
6,525
+700
+12% +$8.34K ﹤0.01% 331
2020
Q2 		$62K Buy
5,825
+1,350
+30% +$13.7K ﹤0.01% 335
2020
Q1 		$36K Buy
4,475
+225
+5% +$1.88K ﹤0.01% 338
2019
Q4 		$34K Sell
4,250
-275
-6% -$2.17K ﹤0.01% 352
2019
Q3 		$34K Buy
+4,525
New +$33.7K ﹤0.01% 344

Other funds holding RDY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GW&K Investment Management's RDY Position: Q1 2024 in Review

GW&K Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 1,075 shares — an estimated $15K sold.

GW&K Investment Management first reported a position in RDY in Q3 2019 and held it in 18 quarters. The position peaked at $103K in Q2 2021. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

  • GW&K Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
  • GW&K Investment Management sold 1,075 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $15K.
  • GW&K Investment Management first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 18 quarters.
  • GW&K Investment Management's Dr. Reddy's Laboratories position peaked at $103K in Q2 2021.
  • 231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on GW&K Investment Management's 13F filing for Q1 2024, filed 8 May 2024.